Effect of Ayurvedic formulation Vidanga Churna and Vyoshadi Guggulu in the Management of Medoroga (Obesity)

Recruitment & Eligibility

Inclusion Criteria

i)Obese subjects of BMI ( >25 to 39.9 kg/m2)

ii)Obese patients of either sex and of age between 18 – 45 years

iii)Willing to participate in the study

Exclusion Criteria

i)Obesity due to secondary causes – Hypothyroidism, PCOD,

Cushing’s syndrome etc.

ii)Patients with poorly controlled Hypertension

(BP > 160 / 100 mm Hg)

iii)Patients with uncontrolled Diabetes Mellitus having HbA1C >8%

iv)Patients who are on corticosteroids, Ca++ channel blockers,

Anti-psychotics, antidepressants, anti-cholinergic, anti-epileptics,

immune-suppressants, Hormonal replacement therapy or any

other drugs that may have an influence on outcome of study.

v)Patients with the H/O significant systemic illness which might

interfere with the compliance of the trail drug (Rheumatoid

arthritis, Tuberculosis, Inflammatory Bowel Disease etc.).

vi)Patients who have a past history of Cardiac Arrhythmia,

Acute Coronary Syndrome, Myocardial Infarction, Stroke

or Severe Arrhythmia in the last 6 months.

vii)Symptomatic patients with clinical evidence of congestive

cardiac failure.

viii)Known cases of HIV and AIDS &Patients suffering with malignancy.

ix) Patients with concurrent serious hepatic disorders (defined as

Aspartate Amino Transferase (AST) and / or Alanine Amino

Transferase (ALT) > 2 times upper normal limit) or Renal Disorders

(defined as S. Creatinine >1.2mg/dL), Severe Pulmonary Dysfunction

(uncontrolled Bronchial Asthma and / or Chronic Obstructive

Pulmonary Disease (COPD)

x) Women who are planning for conception / pregnant or lactating.

xi) H/o hypersensitivity to any of the trial drugs or their ingredients.

xii)Any other condition which the Investigator thinks may jeopardize

the study.

Recruitment & Eligibility